Local FK506 dose‐dependent study using a novel three‐dimensional organotypic assay
Sign Up to like & getrecommendations! Published in 2019 at "Biotechnology and Bioengineering"
DOI: 10.1002/bit.26853
Abstract: Local administration of FK506, an FDA approved immunosuppressant with neuroregenerative properties, is a promising technique to achieve improved peripheral nerve regeneration while preventing the side effects associated with the systemic administration of this drug. Although… read more here.
Keywords: fk506; study; dose; peripheral nerve ... See more keywords